Amundi Increases Stock Holdings in DaVita Inc. $DVA

Key Points

• Amundi increased its stake in DaVita Inc. by 16.0%, holding 517,690 shares worth approximately $79.58 million after purchasing an additional 71,304 shares during the first quarter.
• DaVita reported earnings of $2.95 per share for the latest quarter, exceeding analysts' expectations, with revenue rising 6.1% year-over-year to $3.38 billion.
• Hedge funds and institutional investors currently own 90.12% of DaVita's stock, reflecting strong interest from these entities.

Amundi raised its stake in DaVita Inc. (NYSE:DVA - Free Report) by 16.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 517,690 shares of the company's stock after purchasing an additional 71,304 shares during the period. Amundi owned 0.67% of DaVita worth $79,584,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC increased its stake in DaVita by 2.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company's stock valued at $531,000 after purchasing an additional 69 shares during the last quarter. UMB Bank n.a. increased its stake in DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares during the last quarter. Exchange Traded Concepts LLC increased its stake in DaVita by 8.9% in the first quarter. Exchange Traded Concepts LLC now owns 970 shares of the company's stock valued at $148,000 after purchasing an additional 79 shares during the last quarter. Mather Group LLC. increased its stake in DaVita by 7.0% in the first quarter. Mather Group LLC. now owns 1,201 shares of the company's stock valued at $184,000 after purchasing an additional 79 shares during the last quarter. Finally, National Pension Service increased its stake in DaVita by 74.3% in the first quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after purchasing an additional 84 shares during the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

DaVita Price Performance

Shares of NYSE DVA opened at $137.72 on Friday. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34. The stock has a fifty day moving average price of $139.40 and a 200 day moving average price of $141.85. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60. The company has a market cap of $9.85 billion, a PE ratio of 13.54, a P/E/G ratio of 0.99 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The firm had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same period last year, the company earned $2.00 earnings per share. The company's revenue for the quarter was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Sell-side analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Insider Buying and Selling at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

DVA has been the subject of several research analyst reports. Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a report on Friday, August 22nd. Barclays decreased their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a report on Thursday, August 7th. Finally, Truist Financial set a $148.00 price objective on DaVita in a report on Friday, August 8th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, DaVita presently has a consensus rating of "Hold" and an average target price of $164.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.